Invention Grant
- Patent Title: Pyrazoloquinoline compound
- Patent Title (中): 吡唑并喹啉化合物
-
Application No.: US13788907Application Date: 2013-03-07
-
Publication No.: US08822448B2Publication Date: 2014-09-02
- Inventor: Hiroyuki Kaizawa , Hirofumi Yamamoto , Kazunori Kamijo , Mari Sugita , Ryushi Seo , Satoshi Yamamoto , Atsushi Ukai
- Applicant: Astellas Pharma Inc.
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2010-200403 20100907
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D471/10 ; C07D487/04 ; C07D487/08 ; C07D491/107
Abstract:
The present inventors have investigated a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, bladder/urethral diseases, and the like, and thus, have found that a pyrazoloquinoline compound has a PDE9-inhibiting action, thereby completing the present invention.
Public/Granted literature
- US20130225553A1 PYRAZOLOQUINOLINE COMPOUND Public/Granted day:2013-08-29
Information query
